Catalyst Wire Dossier Catalyst Wire Dossier

ALO-02

oxycodone/naloxone
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALO-02, covering 2012-06-28 to 2018-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers [Phase 1]

See pricing